MDMA THERAPY

Psilohuasca therapy and retreats have been receiving more attention in recent years, particularly among people seeking deeper understanding, emotional processing, or a different perspective on recurring patterns. At the same time, the subject raises understandable questions regarding safety, guidance, integration, and what one should and should not expect from such an experience. In this article, we explain what psilohuasca is, why some retreats offer this combination, the associated risks and uncertainties, and why integration and screening are essential. We also clearly distinguish between information from real-world experience, what is being explored in research, and what you, as a participant, can practically do to minimize risks.

What is psilohuasca (and why do people combine substances)?

Psilohuasca is a combination of psilocybin (usually from truffles or mushrooms) with an MAO inhibitor (MAOi, Monoamine Oxidase Inhibitor). The idea behind this combination is that the MAO inhibitor inhibits certain breakdown processes in the body, which can make the psychedelic experience feel stronger, longer, or different than with psilocybin alone. In retreats and ceremony contexts, this is sometimes presented as a route to deeper introspection or a more “ayahuasca-like” experience, but with psilocybin as the basis.

It is important to know that “stronger” does not automatically mean “better.” For some people, a more intense experience can actually cause more disruption, anxiety, or confusion, especially without proper preparation and professional support. Moreover, the term “therapy” is used in various ways in practice. Sometimes it involves psychological guidance with integration, and sometimes a ceremonial framework with limited aftercare. It pays to examine this critically and ask very specifically what is and is not being offered.

Therapy, ceremony, and research: what does “psilohuasca therapy” actually mean?

When people speak about psilohuasca therapy, they often mean a retreat in which a psychedelic session is combined with guidance, group processes, and integration conversations. That can be valuable, but it is not a guaranteed treatment, nor is it the same as a clinical research protocol. Scientific research into psychedelics typically involves strict selection criteria, medical screening, standardized dosages, safety procedures, and structured psychological support.

In the practice of retreats, this varies greatly by provider. Some venues operate with a thorough intake process, clear contraindications, and experienced guidance. Others are less transparent or offer limited aftercare. The quality of “integration” also varies: from a short group discussion to multiple individual sessions with a therapeutically trained facilitator.

For those exploring their options, it is helpful to bear in mind that a psychedelic experience is not automatically therapeutic in itself. The context, preparation, support during the session, and the way you give meaning to the experience afterward largely determine what you can do with it in daily life.

Safety and risks: the role of MAO inhibition

The main reason to be extra cautious with psilohuasca is the MAO inhibitor. MAO inhibition can cause interactions with food and with various medications and substances. As a result, safety concerns increase compared to psilocybin alone. Exactly which risks are relevant depends on the specific MAO inhibitor, the dosage, an individual's health, and any medication. This is also a significant point of uncertainty: outside of controlled settings, it is often impossible to independently verify exactly which substances and dosages are being used.

In practical terms, this means that a retreat offering psilohuasca must be extra vigilant regarding screening, contraindications, and clear instructions. Think of a thorough intake regarding medication, mental vulnerabilities, and physical risks. There should also be clear information about what you may and may not combine, and why. If a provider remains vague, fails to conduct an intake, or downplays risks, that is a serious warning sign.

Please note: this article does not provide individual medical advice. Discuss questions regarding medication, health, and risks with a qualified physician. Professional assessment is particularly important with MAO inhibition.

Guidance and setting: why ratios, experience, and contingency plan matter

A frequently mentioned quality characteristic in a retreat context is the ratio between facilitators and participants. A lower ratio usually means more personal attention, the ability to intervene more quickly in cases of anxiety or panic, and better observation of physical discomfort. The team's experience also counts: not only experience with ceremonies, but also skills in de-escalation, trauma-sensitive guidance, and recognizing signs of overload.

Always ask about the emergency plan as well. How will a panic reaction, dissociation, or persistent confusion be handled? Is there a quiet room? Who takes charge if things go wrong? Is there a route to medical help if needed? These are practical questions that do not detract from the “spiritual” side of a retreat, but actually contribute to safety.

A safe setting is also predictable: clear start and end times, clear rules, no pressure to “break” anything, and respect for boundaries. In a therapeutic approach, “no” should always be possible, even in the middle of a process.

Integration: from experience to application in daily life

Integration is the process of translating insights, emotions, and experiences from the session into your daily life. Integration is often mentioned in retreats, but its implementation varies. Good integration goes beyond simply “chatting.” It helps organize what has happened, recognize pitfalls (such as hasty conclusions), and take small, achievable steps.

For people with trauma-related symptoms, integration is often especially important. Not because a psychedelic experience is by definition trauma therapy, but because intense sessions can activate hidden or difficult emotions. In such cases, it is valuable to have space for stabilization, setting boundaries, and calmly building meaning. Sometimes, integration also means acknowledging that you do not yet know what something means, and that you need to let it sink in first.

A practical tip is to think about aftercare in advance: will you have peace and quiet after the retreat? Can you reduce sensory overload? Is there someone you trust to talk to? And is there access to professional support, if needed?

Harm reduction: questions you can ask before booking

Harm reduction means minimizing risks as much as possible, even if you cannot control everything. During psilohuasca retreats, you can pay attention to the following points, among others:

First: is there a comprehensive intake with attention to medication, physical health, psychological vulnerability, and previous experiences? Second: how transparent is one regarding the substances used, dosages, and timing? Third: what does the guidance look like during the session, and what is the counselor-participant ratio? Fourth: what integration is offered, and is there also aftercare upon return?

In addition: how are boundaries handled? Is there room to pause, take less, or not continue at all, without social pressure? And: how are participants who cause emotional disruption handled? The way an organization communicates about this often says a lot about the safety culture.

If you want to delve deeper into what providers themselves write about psilohuasca retreats, you can read the forum answer for context via https://trip-forum.nl/qa/psilohuasca-retraites/. Please note that this may primarily contain practical information and experience-based claims, and does not automatically equate to independently tested safety or medical substantiation.

Where does MDMA fit into this landscape (and what is and isn't possible)?

On mdmatherapie.nl, significant attention is focused on MDMA in a therapeutic context, often in relation to trauma and processing. It is important to clearly frame this: MDMA sessions can currently only be discussed within scientific research or in clinical practice in a harm-reduction context. This means that information focuses primarily on safety, preparation, integration, and realistic expectations, not on promises or “quick fixes.”.

Although psilohuasca and MDMA are very different substances, set and setting, screening, and integration are crucial for both. It also holds true for both that personal history, mental resilience, and after-sales support make a major difference in how someone processes an experience.

Conclusion

Psilohuasca therapy in a retreat format is often sought after due to the promise of depth, insight, and emotional processing. At the same time, the MAO inhibitor in particular brings additional points of attention regarding interactions and safety. Anyone considering a retreat would do well to critically examine the intake process, guidance, transparency, emergency procedures, and integration. An intense experience is not automatically therapeutic, but with good preparation and careful aftercare, a retreat can be meaningful for some people.

If you would like to explore guided sessions and guidance regarding preparation and integration more broadly, you can register via https://mdmatherapie.nl/aanmelden-mdma-sessie/. There you will find information about the steps, expectations, and the importance of safety and harm reduction.